Zobrazeno 1 - 9
of 9
pro vyhledávání: '"James F. Conroy"'
Autor:
Pamela Crilley, Isadore Brodsky, J Weiss, James F. Conroy, David Topolsky, S Bulova, J Gryn, Kahn Sb
Publikováno v:
American Journal of Clinical Oncology. 14:52-54
Thirteen patients with leukemia were treated with a combination of cytosine arabinoside (ara-C) (3 g/m2 by 1-h infusion every 12 h for 12 doses) and etoposide (100 mg/m2 daily over 1 h for 3 doses). Toxicity of the regimen consisted of severe hematol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1c9a2997b4b3d97172692adeafdb12
https://doi.org/10.1097/00000421-199102000-00012
https://doi.org/10.1097/00000421-199102000-00012
Publikováno v:
American journal of clinical oncology. 18(4)
The successful development of allogeneic bone marrow transplantation (BMT) has markedly improved the treatment results for acute leukemia and other hematologic diseases. However, significant complications are associated with this procedure including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0ddffa41036a6346c452243baedc1b3
https://pubmed.ncbi.nlm.nih.gov/7625377
https://pubmed.ncbi.nlm.nih.gov/7625377
Autor:
Kelch Bp, David Topolsky, Isadore Brodsky, S Bulova, Peter S. Amenta, James F. Conroy, Kahn Sb, Pamela Crilley
Publikováno v:
American journal of clinical oncology. 13(3)
Recurrent leukemia following allogeneic bone marrow transplantation (BMT) for acute nonlymphocytic leukemia (ANLL) continues to be a cause of morbidity and mortality. Most relapses occur within the first 6-12 months, although disease-free survival cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0b7af208174cf423abe7023819a0621
https://pubmed.ncbi.nlm.nih.gov/2346129
https://pubmed.ncbi.nlm.nih.gov/2346129
Autor:
David Ross, S. B. Kahn, Isadore Brodsky, James F. Conroy, Robert C. Nuss, Luther W. Brady, George C. Lewis
Publikováno v:
Cancer. 37:660-664
Twenty patients with recurrent and disseminated carcinoma of the cervix were treated with Bleomycin, 10 mg/m2 weekly and Methotrexate, 10 mg/m2 every fourth day. Twelve of the 20 (60%) had a greater than 50% shrinking of measured tumor masses lasting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5d9e3674b730d0e49005957d7ea8d0f
https://doi.org/10.1002/1097-0142(197602)37:2<660::aid-cncr2820370208>3.0.co
https://doi.org/10.1002/1097-0142(197602)37:2<660::aid-cncr2820370208>3.0.co
Publikováno v:
Chemotherapy and Radiotherapy of Gastrointestinal Tumors ISBN: 9783642816833
Therapy for metastatic cancer of the colon is a major problem for the medical oncologist. This tumor is refractory to most chemotherapeutic maneuvers. Moertel has noted that the median survival in this group is only 7 months, with a median survival o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbd870d203a818e1bccedccff2d1d4fc
https://doi.org/10.1007/978-3-642-81681-9_10
https://doi.org/10.1007/978-3-642-81681-9_10
Autor:
George C. Lewis, John A. Blessing, Kenneth D. Hatch, George Wilbanks, Charles E. Mangan, James F. Conroy
Publikováno v:
American journal of clinical oncology. 7(2)
Thirty-one patients with advanced squamous cell carcinoma of the cervix were entered onto this phase II study evaluating the efficacy of ICRF-159 (razoxane). Three of these patients were excluded; one had no tumor, one had a second primary, and one r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60e9f10955ec0074d39d03aa9d48a7bd
https://pubmed.ncbi.nlm.nih.gov/6702716
https://pubmed.ncbi.nlm.nih.gov/6702716
Publikováno v:
Urology. 17(6)
A malignant retroperitoneal nonchromaffin paraganglioma in a thirty-four-year-old man was studied by light and electron microscopy. Histologically, the tumor cells displayed a tendency to surround granular, eosinophilic intercellular material and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7108424ce5e875820a887bdde8d599f1
https://pubmed.ncbi.nlm.nih.gov/7245459
https://pubmed.ncbi.nlm.nih.gov/7245459
Publikováno v:
Leukemia research. 3(6)
Twenty-three patients with an established diagnosis of Ph 1 positive chronic myelogenous leukemia have been entered into an experimental study to determine the effect on survival of splenectomy and intensive cycle-active chemotherapy based on serial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b7d4f68268c2f2c28eeb7911a49814d
https://pubmed.ncbi.nlm.nih.gov/297175
https://pubmed.ncbi.nlm.nih.gov/297175
Publikováno v:
American journal of clinical oncology. 5(4)
Hemangiopericytoma is an uncommon sarcoma arising from the pericapillary cells. While the rarity of this lesion precludes randomized investigation, metastatic hemangiopericytoma has been noted to respond to a variety of agents, including vincristine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f673c5a1dd6bbbbff942995848f52d66
https://pubmed.ncbi.nlm.nih.gov/7113966
https://pubmed.ncbi.nlm.nih.gov/7113966